Neurology News

The FDA has granted fast-track designation to a proprietary, scalable, allogeneic, investigational cellular therapy in development to address symptoms of mild Alzheimer’s disease, according to the manufacturer.

The Savings on a Valuable Education (SAVE) plan was introduced in 2023 by the Biden Administration and replaces the Revised Pay As You Earn (REPAYE) program. SAVE continues to evolve with new benefits for student loan borrowers.

The FDA recently approved injectable Kisunla to treat early-stage Alzheimer’s disease, joining Leqembi, which gained FDA approval in July 2023 for the same purpose.

PHILADELPHIA — In this video, Michael Fisher, MD, highlights a keynote presentation given by Charles Limoli, PhD, at the International Symposium on Pediatric Neuro-Oncology.

More than 70 million adults — or one in four — in the United States reported having a disability in 2022, according to a press release from the CDC.

Mushroom-containing nootropic gummies sold at gas stations and smoke shops in Virginia contained unlabeled psilocybin and psilocin, according to results of an investigation published in Morbidity and Mortality Weekly Report.

PHILADELPHIA — In this interview, Michael Fisher, MD, highlights a keynote address presented by Leigh Hochberg, MD, PhD, from the International Symposium on Pediatric Neuro-Oncology.

CHICAGO — Daily avocado intake for half a year did not significantly improve overall cardiovascular health, but it was associated with improvements in certain components, research presented at NUTRITION showed.

Initiation of high-intensity statin therapy during the acute phase of minor, noncardiogenic stroke may increase bleeding risk, according to the results of a Chinese cohort study published in the Journal of the American Heart Association.

Antidopaminergic medications were linked to worsening cognitive and functional effects that accelerate disease progression in Huntington’s disease, according to research presented at the Congress of the European Academy of Neurology.